Michael von Bergwelt-Baildon (LMU, CCC, DKTK, Munich, Germany)

Sebastian Kobold (Ludwig-Maximilians-Universität, Munich, Germany)

Volkmar Nuessler (TZM, Munich, Germany)

Niroshana Anandasabapathy

(Weill Cornell New York, NY, United States)

Michael Bergmann

(Medical University Vienna, Austria)

Mascha Binder

(Universitätsspital Basel, Switzerland)

Marcus Bosenberg

(Yale School of Medicine, New Haven, CT, USA)

Tanja D. de Gruijl

(Cancer Center Amsterdam, The Netherlands)

Lisa Derosa

(Institut de Cancérologie Gustave Roussy, Dep. of Immunotherapy, Villejuif, France)

Ulrich Jäger

(Medical University of Vienna, Austria)

Sebastian Kobold

(Ludwig-Maximilians-Universität, Munich, Germany)

Volkmar Nuessler

(Munich, Germany)

Johanna Olweus

(Institute for Cancer Research, University of Oslo, Norway)

Chong-Xian Pan

(Harvard Medical School, Boston, MA, United States)

Pedro Romero

(Translational Tumor Immunology Group, University of Lausanne, Switzerland)

Maya Saleh

(Director Oncoimmunology Research, Department of Life Sciences and Health, University of Bordeaux, France)

José Saro

(CMO LCB-Novimmune, Switzerland)

Marion Subklewe

(Ludwig-Maximilians-Universität, Munich, Germany)

Eric Tartour

(Hopital Européen Georges-Pompidou, Paris, France)

Christoph Zielinski

(Medical University of Vienna, Austria)